Trials / Terminated
TerminatedNCT04649671
The Effect of Mobile Health-based Exercise on Hepatocellular Carcinoma Patients With Insulin Resistance
The Effect of Mobile Health-based Exercise on Insulin Sensitivity in Hepatocellular Carcinoma Patients With Insulin Resistance: A Randomized Controlled Trial
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 20 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Exercise is predicted to have positive effect among patients with hepatocellular carcinoma (HCC). However, little attention has been paid to the role of physical activity with wearable device in the management of HCC patients in the aspect of improvement in insulin resistance. We designed this study to investigate whether personalized exercise with mobile health program improves insulin resistance without decompensation in HCC patients with insulin resistance.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Mobile health | Perform exercise daily with mobile application and wearable device (warm-up, stretching, aerobic, and strengthening). Mobile application: Hepatocellular carcinoma by Second Doctor Wearable device: Dofit |
Timeline
- Start date
- 2021-03-02
- Primary completion
- 2023-03-02
- Completion
- 2023-03-02
- First posted
- 2020-12-02
- Last updated
- 2023-03-06
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04649671. Inclusion in this directory is not an endorsement.